Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

USP14 decreases the amount of CDH1. 1 / 1

| 1

➶

reach

"A recent study revealed that USP14 knockdown inhibited the migration of breast cancer cells by increasing the expression of vimentin and reducing the expression of E-cadherin, suggesting that USP14 might enhance the metastatic ability of breast cancer cells by initiating the epithelial-mesenchymal transition process.20 However, whether USP14 promotes ESCC metastasis through the same mechanism or other pathways remains unclear."

28509417

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...